AVITA Medical RCEL
$ 11.27
9.42%
Quarterly report 2024-Q2
added 08-08-2024
Country |
Australia |
IPO year |
- |
Industry |
Medical devices |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Dr. Michael S. Perry D.V.M., DVM, Ph.D., FACVPT |
Employees in the company |
98 |
Shares |
25.3 M |
Market Cap[1] |
$ 285 M |
EBITDA (LTM) |
$ -52.6 M |
P/E (LTM) |
- |
P/S (LTM) |
- |
EPS (LTM) |
- |
Other stocks of industry "Medical devices"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.